Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06751056 · ClinicalTrials.gov registry record · NA
Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
A NA study of Pruritus, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06751056: Recruiting NA study of Pruritus, sponsored by Mayo Clinic.
NCT06751056 is a NA study of Pruritus that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 12 participants, below the 110-participant average among 12 other Pruritus trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06751056, a NA study of Pruritus, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.
Primary Outcome
Reported as percentage of reduction in dosage of gabapentin or pregabalin after 12 weeks of home neck traction.
Conditions Studied
Interventions
- DEVICE Cervical Traction Device
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2027-01-10 |
| Phase | NA |
What NCT06751056 shows while recruiting
NCT06751056 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 110-participant average among 12 other Pruritus trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Pruritus appearing as the primary indexed condition, and to 1 intervention - of which Cervical Traction Device is the first listed.
NCT06751056 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06751056 about?
NCT06751056 is a clinical study titled "Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch". The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.
What is the current status of trial NCT06751056?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-06-01. Estimated completion is 2027-01-10.
What conditions does trial NCT06751056 study?
This clinical trial studies the following conditions: Pruritus.
What interventions are being tested in trial NCT06751056?
The interventions under investigation include: Cervical Traction Device (DEVICE).
Who is sponsoring clinical trial NCT06751056?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06751056 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pruritus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06751056's enrollment target sits among peer trials
12 13th of 12 the lowest of 12 other Pruritus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pruritus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients
COMPLETED · NA
-
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
RECRUITING · Phase 3
-
Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli
COMPLETED · Early Phase 1
-
Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI